Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NANOVIRICIDES, INC. Director's Dealing 2013

Mar 12, 2013

34915_dirs_2013-03-11_1b0bac69-ada5-4bdf-b0e1-871882c773ef.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOVIRICIDES, INC. (NNVC.OB)
CIK: 0001379006
Period of Report: 2013-03-06

Reporting Person: Seymour Eugene (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-03-06 Common Stock P 25000 $0.69 Acquired 6025000 Direct

Footnotes

F1: Does not include 500,000 shares of NanoViricides common stock issuable upon exercise of options held by Dr. Seymour that are currently exercisable or will become exercisable within 60 days.